|
2018 US Cholesterol Guidelines: what has changed after 5 years?
Five years on we now have evidence that further substantial lowering of LDL cholesterol with nonstatin therapies translates to greater clinical outcomes benefit in very high risk patients. How have these data been translated to the new guidelines? Read the report »
Read the commentary »
Prof Henry Ginsberg, Columbia University, New York, USA, gives his view of the guidelines.
| 
